ArticleBMC psychology2026
The role of psychological inflexibility on post-traumatic stress symptoms among COVID-19 survivors.
Article in BMC psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 outbreak spread rapidly around the world, causing a pandemic and negatively affecting the mental health of society. During this process, one of the most mentally affected groups has been patients who contracted COVID-19. Post-traumatic stress disorder (PTSD) is reported to be an important public health problem after pandemics. In this study, we aimed to investigate the relationship between psychological inflexibility, which is thought to underlie mental problems and PTSD symptoms in Covid-19 survivors.
methodsA total of 194 patients over 18 years old who were admitted to the Chest Diseases Outpatient Clinic with a previous COVID-19 infection and who agreed to participate were included in the study. Socio-demographic information form as well as questionnaire forms for Hospital Anxiety and Depression Scale (HADS), Acceptance and Action Questionnaire II (AAQ-II), Impact of Events Scale-Revised (IES-R) and Insomnia Severity Index (ISI) were conducted on the patients.
resultsFemale gender, participants with lower education level, and those with additional chronic diseases had significantly higher IES-R values (p = 0.014, p = 0.029 and p = 0.011, respectively). IES-R scores showed a significant positive correlation with HADS-Anxiety (A) (p < 0.001), HADS-Depression (D) (p < 0.001), AAQ-II (p < 0.001) and ISI (p < 0.001) scores. AAQ-II also scores significantly associated with HADS-A scores (p = 0.0053), and similarly, the effect of HADS-A scores on IES-R scores was also significant (p = 0.0009). The mediating role of HADS-A scores in the effect of AAQ-II scores on IES-R scores was significant (β = 0.0757, 95% CI = 0.0024 to 0.1785). AAQ-II scores had a significantly associated with ISI scores (β = 0.1263, p = 0.0033). Similarly, ISI scores had a significant association with IES-R scores (β = 1.3882, p < 0.001). In this model, ISI scores significantly mediated the relationship between AAQ-II scores and IES-R scores (β = 0.1753, 95% CI = 0.0640 to 0.3060).
conclusionIn our study, we found that female gender, low education level and additional chronic diseases were associated with PTSD symptoms in COVID-19 survivors. We also found that psychological inflexibility may be a common factor associated with PTSD, depression and anxiety symptoms and insomnia severity. Psychotherapeutic interventions to reduce psychological inflexibility, especially in patients who suffered an infection like COVID-19 during the pandemics, may prevent these patients from experiencing anxiety, depression, PTSD symptoms and sleep problems.
Indexed as
Identifiers
42919423What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.